COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 1882: Articles 18811-18820  | Next

Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
Noy-Porat, T., Mechaly, A., Levy, Y., Makdasi, E., Alcalay, R., Gur, D., Aftalion, M., Falach, R., Leviatan Ben-Arye, S., Lazar, S., Zauberman, A., Epstein, E., Chitlaru, T., Weiss, S., Achdout, H., Edgeworth, J. D., Kikkeri, R., Yu, H., Chen, X., Yitzhaki, S., Shapira, S. C., Padler-Karavani, V., Mazor, O., Rosenfeld, R.
10.1101/2021.02.02.428995 — Posted: 2021-02-02
A Thermostable, Flexible RNA Vaccine Delivery Platform for Pandemic Response
Gerhardt, A., Voigt, E., Archer, M., Reed, S., Larson, E., Van Hoeven, N., Kramer, R., Fox, C., Casper, C.
10.1101/2021.02.01.429283 — Posted: 2021-02-02
Dynamics of SARS-CoV-2-specific antibodies during and after COVID19: Lessons from a biobank in Argentina
Longueira, Y., Polo, M. L., InViV working group, , Turk, G., Laufer, N., Biobanco de Enfermedades Infecciosas Coleccion COVID19 working group
10.1101/2021.01.31.21250167 — Posted: 2021-02-02
Molecular epidemiology of SARS-CoV-2 in Greece reveals low rates of onward virus transmission after lifting of travel restrictions based on risk assessment during summer 2020
Kostaki, E. G., Pavlopoulos, G. A., Verrou, K.-M., Ampatziadis-Michailidis, G., Harokopos, V., Hatzis, P., Moulos, P., Siafakas, N., Pournaras, S., Hadjichristodoulou, C., Chatzopoulou, F., Chatzidimitriou, D., Panagopoulos, P., Lourida, P., Argyraki, A., Lytras, T., Sapounas, S., Gerolymatos, G., Panagiotakopoulos, G., Prezerakos, P., Tsiodras, S., Sypsa, V., Hatzakis, A., Anastassopoulou, C., Spanakis, N., Tsakris, A., Dimopoulos, M. A., Kotanidou, A., Sfikakis, P., Kollias, G., Magiorkinis, G., Paraskevis, D.
10.1101/2021.01.31.21250868 — Posted: 2021-02-02
Genetic determination of regional connectivity in modelling the spread of COVID-19 outbreak for improved mitigation strategies
Salichos, L., Warrell, J., Cevasco, H., Chung, A., Gerstein, M.
10.1101/2021.01.30.21250785 — Posted: 2021-02-02
Who should be first in line for the COVID-19 vaccine? Surveys in 13 countries of the publics preferences for prioritisation
Duch, R., Roope, L. S. J., Violato, M., Becerra, M. F., Robinson, T., Bonnefon, J.-F., Friedman, J., Loewen, P., Mamidi, P., Melegaro, A., Blanco, M., Vargas, J., Seither, J., Candio, P., Cruz, A. G., Hua, X., Barnett, A., Clarke, P.
10.1101/2021.01.31.21250866 — Posted: 2021-02-02
Successful reboot of high-performance sporting activities by Japanese national women's handball team in Tokyo, 2020 during the COVID-19 pandemic: An initiative by Japan Sports-Cyber Physical System (JS-CPS) of Sports Research Innovation Project (SRIP)
Ogasawara, I., Hamaguchi, S., Hasegawa, R., Akeda, Y., Ota, N., Revankar, G. S., Konda, S., Taguchi, T., Takanouchi, T., Imoto, K., Okimoto, N., Sakuma, K., Uchiyama, A., Yamasaki, K., Higashino, T., Tomono, K., Nakata, K.
10.1101/2021.01.29.21250745 — Posted: 2021-02-02
COVID-19 risk perceptions of social interaction and essential activities and inequity in the United States: Results from a nationally representative survey
Erchick, D. J., Zapf, A. J., Baral, P., Edwards, J., Mehta, S. H., Solomon, S. S., Gibson, D. G., Agarwal, S., Labrique, A. B.
10.1101/2021.01.30.21250705 — Posted: 2021-02-02
A Logistic Formula in Biology and Its Application to Deaths by the Third Wave of COVID-19 in Japan
Saito, T.
10.1101/2021.01.30.21250827 — Posted: 2021-02-02
Sustainable targeted interventions to mitigate the COVID-19 pandemic: A big data-driven modeling study in Hong Kong
ZHOU, H., Zhang, Q., Cao, Z., Huang, H., Zeng, D.
10.1101/2021.01.29.21250786 — Posted: 2021-02-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).